Singapore markets closed

Enanta Pharmaceuticals, Inc. (ENTA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
12.66-0.27 (-2.05%)
As of 03:15PM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts7788
Avg. Estimate-1.44-1.37-5.72-5.16
Low estimate-1.73-1.78-6.3-6.14
High estimate-1.18-0.91-5.14-4.39
Year ago EPS-1.86-1.33-6.38-5.72
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts7767
Avg. Estimate17.46M17.57M69.1M74.03M
Low estimate15.12M16M67.59M63M
High estimate20M21M71.5M111.94M
Year ago salesN/A18.93M79.2M69.1M
Sales growth (year/est)N/A-7.20%-12.80%7.10%
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-2.34-2.15-1.19-1.33
Actual EPS-1.86-1.33-1.58-1.47
Difference0.480.82-0.39-0.14
Surprise %20.50%38.10%-32.80%-10.50%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-1.44-1.37-5.72-5.16
7 days ago-1.23-1.03-5.09-4.67
30 days ago-1.23-1.03-5.09-4.67
60 days ago-1.23-1.03-5.09-4.67
90 days ago-1.25-1.02-5.26-4.8
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 days1112
Up last 30 days1112
Down last 7 daysN/AN/AN/AN/A
Down last 30 days5565
Growth estimatesENTAIndustrySector(s)S&P 500
Current qtr.22.60%N/AN/AN/A
Next qtr.-3.00%N/AN/AN/A
Current year10.30%N/AN/AN/A
Next year9.80%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)-10.60%N/AN/AN/A